Charles River Laboratories International (CRL) News Today $163.76 -2.04 (-1.23%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Charles River Laboratories International Inc. stock underperforms Friday when compared to competitorsJanuary 17 at 9:22 PM | marketwatch.comCharles River Labs: Near A Fundamental Trough, Growth Should Reignite AgainJanuary 17 at 4:22 PM | seekingalpha.comUBS Downgrades Charles River Laboratories International (CRL)January 17 at 4:22 PM | msn.comHold Rating for Charles River Labs Amid Supply Chain Challenges and Mitigation StrategiesJanuary 17 at 11:21 AM | markets.businessinsider.comCharles River Labs downgraded to neutral by UBSJanuary 17 at 11:21 AM | msn.comUBS Group Reiterates Neutral Rating for Charles River Laboratories International (NYSE:CRL)UBS Group reiterated a "neutral" rating and set a $185.00 price objective (down from $250.00) on shares of Charles River Laboratories International in a research report on Friday.January 17 at 6:43 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sets New 52-Week Low - Here's WhyCharles River Laboratories International (NYSE:CRL) Reaches New 12-Month Low - What's Next?January 17 at 5:46 AM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sees Unusually-High Trading Volume - Still a Buy?Charles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Here's WhyJanuary 16 at 1:25 PM | marketbeat.comCharles River CEO reveals drop in 2025 revenue outlook at JP MorganJanuary 16 at 11:03 AM | finance.yahoo.comEvercore ISI Sticks to Their Hold Rating for Charles River Labs (CRL)January 16 at 11:03 AM | markets.businessinsider.comCharles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy PlatformJanuary 16 at 11:03 AM | finance.yahoo.comCharles River Partners Akron Bio To Boost Integration Of CGMP Materials Into Cell Therapy PlatformJanuary 16 at 11:03 AM | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Earns "Outperform" Rating from William BlairJanuary 16 at 4:23 AM | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Reaches New 1-Year Low - Here's WhyCharles River Laboratories International (NYSE:CRL) Sets New 52-Week Low - Here's WhyJanuary 15 at 5:01 AM | marketbeat.comCharles River Laboratories International's (CRL) "Outperform" Rating Reiterated at William BlairWilliam Blair reaffirmed an "outperform" rating on shares of Charles River Laboratories International in a research report on Tuesday.January 14 at 12:21 PM | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Gap Down - What's Next?Charles River Laboratories International (NYSE:CRL) Shares Gap Down - Here's What HappenedJanuary 14 at 11:52 AM | marketbeat.comReinhart Partners LLC. Has $9.36 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Reinhart Partners LLC. lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 18.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 50,676 shares of theJanuary 13, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Consensus Recommendation of "Reduce" from AnalystsCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has been given an average rating of "Reduce" by the fifteen brokerages that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, ten have issued a hold recomJanuary 13, 2025 | marketbeat.comFirst Hawaiian Bank Trims Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)First Hawaiian Bank cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 57.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,476 shares of the medical reJanuary 11, 2025 | marketbeat.comJPMorgan Chase & Co. Has $95.09 Million Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)JPMorgan Chase & Co. lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 482,745 shares of the medical research company's stockJanuary 3, 2025 | marketbeat.comZacks Research Issues Negative Forecast for CRL EarningsCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for shares of Charles River Laboratories International in a report issued on Tuesday, December 24th. Zacks Research analyst R. DepaDecember 27, 2024 | marketbeat.comCharles River Laboratories International Inc. stock rises Tuesday, still underperforms marketDecember 24, 2024 | marketwatch.comCharles River Laboratories International Inc. stock underperforms Thursday when compared to competitorsDecember 20, 2024 | marketwatch.comEarnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospectsDecember 20, 2024 | finance.yahoo.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Reduce" from AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have earned an average rating of "Reduce" from the fifteen analysts that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, ten have issued aDecember 19, 2024 | marketbeat.comSanctuary Advisors LLC Has $3.40 Million Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Sanctuary Advisors LLC cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 26.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,379 shares of the medical research company's stock aDecember 17, 2024 | marketbeat.comCautious Hold Rating for Charles River Labs Amid Stable Projections and Slight Price Target AdjustmentDecember 17, 2024 | markets.businessinsider.comLord Abbett & CO. LLC Buys 5,959 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Lord Abbett & CO. LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 108,715 shares of the medDecember 16, 2024 | marketbeat.comVirtu Financial LLC Buys New Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Virtu Financial LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,051 shares of the medical research company's stDecember 15, 2024 | marketbeat.comBarclays PLC Lowers Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Barclays PLC reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 20.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 130,826 shares of the medical researchDecember 14, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Price Target Cut to $210.00 by Analysts at Bank of AmericaBank of America decreased their target price on Charles River Laboratories International from $220.00 to $210.00 and set a "neutral" rating for the company in a research note on Friday.December 13, 2024 | marketbeat.comTD Private Client Wealth LLC Lowers Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)TD Private Client Wealth LLC reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,342 shares of the medical reDecember 13, 2024 | marketbeat.comNational Bank of Canada FI Purchases 6,627 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)National Bank of Canada FI grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 45.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,216 shares of the medical research company's stock afterDecember 13, 2024 | marketbeat.com4,902 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Neo Ivy Capital ManagementNeo Ivy Capital Management purchased a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,902 shares ofDecember 12, 2024 | marketbeat.comGould Capital LLC Acquires New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Gould Capital LLC bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 6,217 shares of the medical research company's stock, valued at approximateDecember 10, 2024 | marketbeat.comState Street Corp Buys 41,421 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)State Street Corp boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,130,279 shares of the medical research companyDecember 10, 2024 | marketbeat.comStifel Financial Corp Decreases Position in Charles River Laboratories International, Inc. (NYSE:CRL)Stifel Financial Corp decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 9.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100,593 shares of the medical research company's stock after sellingDecember 10, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Trimmed by Fmr LLCFmr LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 70.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 134,292 shares of the medical research company's stock afterDecember 10, 2024 | marketbeat.comQuadrature Capital Ltd Sells 41,941 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Quadrature Capital Ltd cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 92.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,470 shares of the medical research companyDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Quantinno Capital Management LPQuantinno Capital Management LP grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,706 sharesDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Janus Henderson Group PLCJanus Henderson Group PLC raised its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 7.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,018 shares of the medDecember 9, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by iA Global Asset Management Inc.iA Global Asset Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5,383.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,030 shareDecember 8, 2024 | marketbeat.comCharles River Introduces Global Biotech Incubator ProgramDecember 5, 2024 | finance.yahoo.comCentiva Capital LP Takes $1.43 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Centiva Capital LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,265 shares of the medical researchDecember 4, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange CommissioDecember 4, 2024 | marketbeat.comCharles River Laboratories to Present at Evercore ISI Investor ConferenceDecember 2, 2024 | gurufocus.comBellevue Group AG Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Bellevue Group AG lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 68.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,115 sharDecember 1, 2024 | marketbeat.comAmerican Capital Management Inc. Sells 35,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)American Capital Management Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 19.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,800 shares of the medical resDecember 1, 2024 | marketbeat.comPDT Partners LLC Sells 3,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)PDT Partners LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,263 shares of the medical research company's stock after selliDecember 1, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Buys Shares of 14,800 Charles River Laboratories International, Inc. (NYSE:CRL)Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,800 shDecember 1, 2024 | marketbeat.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.320.72▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼227▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts